tiprankstipranks
NewsSmart PortfolioMarkets
Top Stocks
Daily Feeds
Tools
Calendars
Top Smart Score Stocks
New
Analysts' Top StocksInsiders' Hot Stocks
Popular
Trending Stocks
Research Tools
My Portfolio
My Watchlists
Profile & Performance
OverviewMy HoldingsMy Portfolio AnalysisCrowd Insights
Smart Portfolio
Top Smart Score Stocks
New
Analysts' Top StocksInsiders' Hot Stocks
Popular
Trending Stocks
Top Stocks
Find & Follow Experts
Top Lists
My ExpertsExpert CenterTop Firms
Top Experts
Categories
Trending Topics
HomeMarket NewsTipRanks LabsIdeas & InsightsStock Analysis
News
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About us
About TipRanksReviewsContact Us
Work With Us
CareersAffiliate
TipRanks For Business
For BrokersFor Hedge FundsFor Investment AdvisorsFor Academic Research
Company Policy
FAQPrivacy PolicyTerms of UseEducation Center
Follow Us On
YouTubeTwitterStocktwitsFacebookInstagramLinkedin
About Us
Plans & Pricing
NewsSmart PortfolioMarketsNotifications
Welcome
LoginSign Up
NotificationsMy Watchlist
Research Tools
Top Smart Score StocksAnalysts' Top StocksInsiders' Hot StocksTrending Stocks
HomeMarket NewsStock AnalysisTipRanks LabsIdeas & Insights
Daily Stock RatingsDaily Insider Transactions
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock ComparisonAirline StocksBank StocksBiotech StocksBitcoin StocksCannabis StocksCasino StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksElectric Vehicles StocksFAANG StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksRenewable Energy StocksStay-At-Home StocksWallStreetBets StocksWork-From-Home Stocks
Stock ScreenerPenny StocksWebsite Traffic Screener
Dividend Calculator
Earnings CalendarsDividend CalendarsStock Market HolidaysIPO Calendar
Smart Portfolio
OverviewMy HoldingsMy Performance
My Portfolio AnalysisCrowd InsightsMy Public Profile
Account & More
LoginTipRanks PremiumPlans & Pricing
About TipRanksFAQAPI for InstitutionsBecome an AffiliateCareersContact Us
All News

GlaxoSmithKline Stock Latest News

GlaxoSmithKline Gains, Consumer Unit Sale May Be Ahead
GlaxoSmithKline Gains, Consumer Unit Sale May Be Ahead
GlaxoSmithKline (GSK) is well-known as a maker of various medications. The company has a huge presence in vaccines,...
Steve Anderson
GSK
Alector Surging on GlaxoSmithKline Deal; Analyst Remains Positive
Alector Surging on GlaxoSmithKline Deal; Analyst Remains Positive
Alector Inc. (ALEC), a clinical stage biotechnology company, has been in the headlines recently. With a market capitalization...
Shalu Saraf
GSKALEC
Alector Signs Global Agreement with Glaxo for Development of Two Neurodegenerative Disease Antibodies; Shares Surge 57%
Alector Signs Global Agreement with Glaxo for Development of Two Neurodegenerative Disease Antibodies; Shares Surge 57%
Global healthcare firm GlaxoSmithKline (GSK) and San Francisco-based biotechnology company Alector Inc. (ALEC) have signed a global agreement...
Richika Biyani
GSKALEC
GSK to Spin-Off Consumer Healthcare Business by Mid-2022; Provides Outlook
GSK to Spin-Off Consumer Healthcare Business by Mid-2022; Provides Outlook
The global pharmaceutical company GlaxoSmithKline plc (GSK) announced the strategic separation of its Consumer Healthcare business, to be...
Sheryl Sheth
GSK
Halozyme Collaborates with ViiV Healthcare to Develop Ultra-Long-Acting HIV Meds
Halozyme Collaborates with ViiV Healthcare to Develop Ultra-Long-Acting HIV Meds
Biopharmaceutical company Halozyme Therapeutics (HALO) has entered into a global collaboration and licensing agreement with ViiV Healthcare to...
Kailas Salunkhe
GSKPFEHALO
GlaxoSmithKline & Vir Biotechnology’s Sotrovimab Antibody Cleared for Emergency Use in the U.S.
GlaxoSmithKline & Vir Biotechnology’s Sotrovimab Antibody Cleared for Emergency Use in the U.S.
GlaxoSmithKline (GSK) and Vir Biotechnology’s (VIR) investigational single-dose monoclonal antibody sotrovimab (previously named VIR-7831) has been authorized for...
Priti Ramgarhia
GSKVIR
Sanofi, GSK Ink Covax Supply Deal For 200M Covid Vaccine Doses
Sanofi, GSK Ink Covax Supply Deal For 200M Covid Vaccine Doses
Sanofi (SNYNF) and GlaxoSmithKline (GSK) intend to make available 200 million doses of their adjuvanted recombinant protein-based COVID-19...
Harriet Lefton
GSKSNYNF
Sanofi, GSK To Kick Off Human Trials Of Covid-19 Candidate
Sanofi, GSK To Kick Off Human Trials Of Covid-19 Candidate
French drugmaker Sanofi and GlaxoSmithKline announced the start of the Phase 1/2 human clinical trial for their adjuvanted...
Sharon Wrobel
GSKSNYNF
Sanofi, GSK Nearing EU Supply Deal For 300M Covid-19 Vaccine Doses
Sanofi, GSK Nearing EU Supply Deal For 300M Covid-19 Vaccine Doses
Sanofi (SNYNF) and and GlaxoSmithKline (GSK) are in advanced discussions with the European Commission (EC) for the supply...
Harriet Lefton
GSK
Sanofi, GSK Ink $2.1B Covid-19 Vaccine Deal From US Government
Sanofi, GSK Ink $2.1B Covid-19 Vaccine Deal From US Government
French drugmaker Sanofi (SNYNF) and GlaxoSmithKline (GSK) will be granted up to $2.1 billion by the U.S. government...
Sharon Wrobel
GSKSNYNF
Sanofi, GSK Agree UK Supply Deal For 60M Covid-19 Vaccine Doses
Sanofi, GSK Agree UK Supply Deal For 60M Covid-19 Vaccine Doses
Sanofi (SNYNF) and GSK (GSK) have now confirmed an agreement with the UK government for the supply of...
Harriet Lefton
GSK
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
GlaxoSmithKline (GSK) will buy a 10% stake in Germany’s CureVac as part of a strategic collaboration to develop...
Sharon Wrobel
GSK